[O-06-1] Development of FABP3 ligands inhibiting alpha-synuclein oligomerization in Parkinson's disease
Abstract password authentication.
Password is written on a pocket program and name badge.
Presentation information
Oral Session
[O-06] Parkinsonism and Related disorders （Basic research）
Wed. May 22, 2019 3:35 PM - 5:05 PM Room 9 (Osaka International Convention Center 12F Conference Hall)
Chair:Masahiro Nagai(Clinical therapeutic trial center, Ehime university hospital) Commentator:Seung-jae Lee(Department of Biomedical Sciences, Seoul National University College of Medicine)